Amgen (AMGN) Protective Put Calculator
Calculator · free · no signup · AMGNPrice a protective put, zero-cost collar, or put spread on Amgen. Annual cost, max loss, upside cap, tax treatment, auto-filled from current AMGN option chain.
AlphaLatitude Inc. · Free ToolsOur tools respect your browsing privacy. Independently verified:
You priced one hedge. The beta picks the right hedge structure given your full equity stack and tax situation.
Request beta access →Related calculators: Stock Concentration Calculator
About Amgen
Amgen (AMGN) is a public Pharma/Biotech company, incorporated in Delaware and headquartered in Thousand Oaks, CA.
Last close: $421.51 per share (as of 2026-10-01).
Equity grants at Amgen typically include restricted stock units (RSUs).
Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. The company is ranked 18th on the list of largest biomedical companies by revenue. The name "AMGen" is a portmanteau of the company's original name, Applied Molecular Genetics.
Source: Wikipedia (CC BY-SA 4.0)
Amgen was incorporated in Thousand Oaks, California on April 8, 1980, with George Rathmann as its first CEO and UCLA molecular biologist Winston Salser among its scientific founders. The company develops and manufactures biologic drugs (medicines produced from living cells rather than synthesized chemicals), including Repatha for cholesterol and Prolia for osteoporosis. Its 2023 acquisition of Horizon Therapeutics for $27.8 billion added rare-disease treatments Tepezza and Krystexxa, which combined for roughly $3 billion in 2025 revenue. Full-year 2025 product sales reached $35.1 billion, reported in Amgen's Q4 2025 results released February 2026.
Sources: amgen.com · amgen.com · stocktitan.net
Equity comp at Amgen
- RSUs use single-trigger vesting: shares become yours as each portion vests on schedule, and the value is taxed as ordinary income at that point. No IPO or acquisition is required.
Researched 2026-08-17.
OptionsAhoy is an independent tool and is not affiliated with, endorsed by, or sponsored by Amgen.
A protective put caps your downside on the AMGN position at a chosen floor; a zero-cost collar pays for that floor by capping the upside. This calculator prices both structures off the current AMGN option chain, with annual cost, max loss, and tax-treatment notes.
Example: a 5,000-share AMGN position at $421.51 is worth $2,107,550. A 1-year 30%-OTM put on that position typically runs 2-4% of position value per year (about $42,151 to $84,302) before any premium offset from a short call. The calculator prices both structures off AMGN's current option chain so you see the actual cost for your chosen floor, tenor, and cap.
All Amgen tools → · Use the generic Protect Your Stock Calculator for any company.
Amgen equity questions
- How much does it cost to hedge AMGN stock?
- The cost of a protective put depends on how far below the current price you set the floor, how long the protection lasts, and AMGN's option-implied volatility. A zero-cost collar lowers that cost by selling away some upside. The calculator above prices both structures off the current AMGN option chain and shows the annual cost, maximum loss, and tax treatment.
- Does Amgen grant ISOs, NSOs, or RSUs?
- Equity compensation at Amgen typically takes the form of restricted stock units (RSUs). Restricted stock units are taxed as ordinary income when they vest.
- Do Amgen RSUs use double-trigger vesting?
- No. Amgen restricted stock units (RSUs) use single-trigger vesting: each tranche becomes yours as it vests on schedule, taxed as ordinary income at that point, with no liquidity event required.
Find another companyPharma/Biotech peers
One piece of the puzzle.
OptionsAhoy plans your Amgen equity alongside hedging, vesting, and de-concentration, across bullish, neutral, and bearish market scenarios. Free during beta.